Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.

Arnold Egloff SA, Du L, Loomans HA, Starchenko A, Su PF, Ketova T, Knoll PB, Wang J, Haddad AQ, Fadare O, Cates JM, Lotan Y, Shyr Y, Clark PE, Zijlstra A
Oncotarget. 2017 8 (1): 722-741

PMID: 27894096 · PMCID: PMC5352192 · DOI:10.18632/oncotarget.13546

MeSH Terms (18)

Activated-Leukocyte Cell Adhesion Molecule Aged Biomarkers, Tumor Cohort Studies Computational Biology Cystectomy Databases, Genetic Female Gene Expression Gene Expression Profiling Humans Male Middle Aged Neoplasm Staging Prognosis Proportional Hazards Models Reproducibility of Results Urinary Bladder Neoplasms

Connections (4)

This publication is referenced by other Labnodes entities: